Apollo entities seek CCI nod for recast plan

Share this post on:
Apollo Group entities have sought the Competition Commission of India’s (CCI) approval for a composite restructuring plan that would eventually lead to the separate listing of the group’s omnichannel pharmacy and digital health businesses within 18-21 months.

The proposal involves the demerger of omnichannel pharmacy distribution, Apollo 24|7 digital platform and remote telehealth division of Apollo Hospitals Enterprise (AHEL) into a new company-Apollo Healthtech (AHTL).

Subsequently, Keimed, another group entity that focusses on wholesale pharmacy business, will be merged into this new company. This will create a formidable listed omnichannel pharmacy distribution and digital health platform leader in India with ₹16,300 crore in revenues in FY25, AHEL had said in June. This combined entity was proposed to be listed in 18-21 months.

According to the filing of the group entities with the antitrust regulator dated July 30, the new company will then acquire 74.5% shareholding of Apollo Medicals (AMPL) from existing shareholders in accordance with the applicable regulatory framework and a share purchase agreement already executed for this purpose.

Manipal seeks nod too


Separately, Manipal Hospitals, an arm of Manipal Health Enterprises, has sought the CCI clearance to acquire 100% of Sahyadri Hospitals in multiple tranches, according to a separate filing with the regulator dated July 30.

Share this post on:

Leave a Reply

Your email address will not be published. Required fields are marked *